David S. Burt

2.0k total citations
53 papers, 1.6k citations indexed

About

David S. Burt is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, David S. Burt has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 31 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in David S. Burt's work include Influenza Virus Research Studies (25 papers), Immune Response and Inflammation (12 papers) and Immune Cell Function and Interaction (11 papers). David S. Burt is often cited by papers focused on Influenza Virus Research Studies (25 papers), Immune Response and Inflammation (12 papers) and Immune Cell Function and Interaction (11 papers). David S. Burt collaborates with scholars based in Canada, United Kingdom and United States. David S. Burt's co-authors include George H. Lowell, D.R. Stanworth, Sonya Cyr, D. B. Thomas, J.J. Skehel, Howard L. Weiner, Dan Frenkel, Ruth Maron, Michel Klein and B C Barnett and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

David S. Burt

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David S. Burt Canada 27 778 669 354 333 182 53 1.6k
Oretta Finco Italy 24 1.0k 1.3× 554 0.8× 657 1.9× 410 1.2× 206 1.1× 48 2.2k
H. F. Sewell United Kingdom 19 473 0.6× 420 0.6× 440 1.2× 206 0.6× 83 0.5× 43 1.5k
Hartwig P. Huemer Austria 26 458 0.6× 542 0.8× 240 0.7× 347 1.0× 109 0.6× 70 1.5k
Innocent N. Mbawuike United States 22 933 1.2× 1.0k 1.5× 483 1.4× 300 0.9× 103 0.6× 38 1.9k
S Marshall-Clarke United Kingdom 17 909 1.2× 366 0.5× 198 0.6× 220 0.7× 107 0.6× 40 1.7k
J R McGhee United States 26 1.2k 1.6× 289 0.4× 403 1.1× 215 0.6× 155 0.9× 59 2.1k
J H Schumacher United States 9 1.7k 2.2× 391 0.6× 299 0.8× 173 0.5× 228 1.3× 9 2.5k
Laurie Love-Homan United States 16 1.2k 1.5× 415 0.6× 487 1.4× 169 0.5× 40 0.2× 23 1.9k
Elena Giacomini Italy 24 1.7k 2.2× 819 1.2× 468 1.3× 911 2.7× 49 0.3× 59 2.8k
Pearl Gray United States 13 1.9k 2.4× 433 0.6× 552 1.6× 129 0.4× 74 0.4× 14 2.4k

Countries citing papers authored by David S. Burt

Since Specialization
Citations

This map shows the geographic impact of David S. Burt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Burt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Burt more than expected).

Fields of papers citing papers by David S. Burt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Burt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Burt. The network helps show where David S. Burt may publish in the future.

Co-authorship network of co-authors of David S. Burt

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Burt. A scholar is included among the top collaborators of David S. Burt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Burt. David S. Burt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Weiping, Jin Hyang Kim, A. Reber, et al.. (2017). Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice. Vaccine. 35(25). 3318–3325. 10 indexed citations
2.
Allen, Elizabeth, et al.. (2015). AS03-Adjuvanted, Very-Low-Dose Influenza Vaccines Induce Distinctive Immune Responses Compared to Unadjuvanted High-Dose Vaccines in BALB/c Mice. Frontiers in Immunology. 6. 207–207. 28 indexed citations
3.
Burt, David S., et al.. (2013). Immunologic characterization of a novel inactivated nasal mumps virus vaccine adjuvanted with Protollin. Vaccine. 32(2). 238–245. 5 indexed citations
4.
Frenkel, Dan, Lindsay Puckett, Weiming Xia, et al.. (2008). A nasal proteosome adjuvant activates microglia and prevents amyloid deposition. Annals of Neurology. 63(5). 591–601. 44 indexed citations
5.
Pasetti, Marcela F., Aldo Arturo Reséndiz‐Albor, Karina Ramírez, et al.. (2007). Heterologous Prime–Boost Strategy to Immunize Very Young Infants against Measles: Pre-clinical Studies in Rhesus Macaques. Clinical Pharmacology & Therapeutics. 82(6). 672–685. 27 indexed citations
6.
Chabot, Sophie, M. Shawi, Jessica Wagner, et al.. (2007). TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces. Vaccine. 25(29). 5348–5358. 37 indexed citations
7.
8.
Adamovicz, Jeffrey J., Sonya Cyr, C R Bolt, et al.. (2005). Intranasal Protollin™/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. Vaccine. 24(10). 1625–1632. 46 indexed citations
9.
Langley, Joanne M., Scott A. Halperin, Shelly McNeil, et al.. (2005). Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults. Vaccine. 24(10). 1601–1608. 37 indexed citations
10.
11.
Jones, Taff, et al.. (2004). Protollin™: a novel adjuvant for intranasal vaccines. Vaccine. 22(27-28). 3691–3697. 37 indexed citations
12.
Sambhara, Suryaprakash, Renata Lima de Miranda, Olive James, et al.. (2001). Severe Impairment of Primary but Not Memory Responses to Influenza Viral Antigens in Aged Mice: Costimulation in Vivo Partially Reverses Impaired Primary Immune Responses. Cellular Immunology. 210(1). 1–4. 34 indexed citations
13.
Ennis, Francis A., John Cruz, Julie Jameson, et al.. (1999). Augmentation of Human Influenza A Virus-Specific Cytotoxic T Lymphocyte Memory by Influenza Vaccine and Adjuvanted Carriers (ISCOMS). Virology. 259(2). 256–261. 82 indexed citations
14.
Sambhara, Suryaprakash, Brian J. Underdown, Michel Klein, et al.. (1998). Heterotypic Protection against Influenza by Immunostimulating Complexes Is Associated with the Induction of Cross‐Reactive Cytotoxic T Lymphocytes. The Journal of Infectious Diseases. 177(5). 1266–1274. 43 indexed citations
15.
Thomas, D. B., David S. Burt, B C Barnett, Christine M. Graham, & J.J. Skehel. (1989). B- and T-cell Recognition of Influenza Hemagglutinin. Cold Spring Harbor Symposia on Quantitative Biology. 54(0). 487–495. 6 indexed citations
16.
Mills, Kingston H. G., David S. Burt, J.J. Skehel, & D. B. Thomas. (1988). Fine specificity of murine class II-restricted T cell clones for synthetic peptides of influenza virus hemagglutinin. Heterogeneity of antigen interaction with the T cell and the Ia molecule.. The Journal of Immunology. 140(12). 4083–4090. 22 indexed citations
17.
Sharif, Najam A., William B. White, & David S. Burt. (1987). Properties and distribution of TRH receptors in normal and spastic mutant mouse brain and spinal cord. Neurochemistry International. 11(1). 63–68. 5 indexed citations
18.
Jackson, Natalie, David S. Burt, J Crocker, & B. J. Boughton. (1987). Skin mast cells in polycythaemia vera relationship to the pathogenesis and treatment of pruritus. British Journal of Dermatology. 116(1). 21–29. 55 indexed citations
19.
Burt, David S., Gillian Z. Hastings, John F. Healy, & D.R. Stanworth. (1987). Analysis of the interaction between rat immunoglobulin e and rat mast cells using anti-peptide antibodies. Molecular Immunology. 24(4). 379–389. 16 indexed citations
20.
Burt, David S., Gillian Z. Hastings, & D.R. Stanworth. (1986). Use of synthetic peptides in the production and characterization of antibodies directed against predetermined specificities in rat immunoglobulin E. Molecular Immunology. 23(2). 181–191. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oretta Finco Breakdown of academic impact, for papers by H. F. Sewell Breakdown of academic impact, for papers by Hartwig P. Huemer Breakdown of academic impact, for papers by Innocent N. Mbawuike Breakdown of academic impact, for papers by S Marshall-Clarke Breakdown of academic impact, for papers by J R McGhee Breakdown of academic impact, for papers by J H Schumacher Breakdown of academic impact, for papers by Laurie Love-Homan Breakdown of academic impact, for papers by Elena Giacomini Breakdown of academic impact, for papers by Pearl Gray
Rankless by CCL
2026